Med BioGene Inc

MBI-H · V · Healthcare / Diagnostics & Research

0.02CAD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.02

Open0.02

Day Range0.02 – 0.02

52-Week Range0.02 – 0.04

Volume0

Market Cap345.16K

P/E (TTM)0.00

Forward P/E0.00

EPS0.00

Dividend Yield0.00%

Beta1.54

50-Day Avg0.0274

200-Day Avg0.0246

About

Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was involved in the life science business with a focus on the commercialization of prognostic genomic-based tests for non-small-cell lung cancer. It also focuses on the commercialization of technologies in various industrial sectors. The company is headquartered in Vancouver, Canada.

Company Details

SectorHealthcare
IndustryDiagnostics & Research
CEODr. Iain Weir-Jones FGS, P.Eng., Ph.D.
Employees0
Headquarters598 East Kent Avenue South, Vancouver, BC, Canada, V5X 4V6, Canada
Websitehttps://www.medbiogene.com

Leadership

Dr. Iain Weir-Jones FGS, P.Eng., Ph.D.President, Chairman & CEO
Mr. Ibrahim GhobrialCFO & Corporate Secretary

Financials

Income Statement

Currency: USD	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	-	0	0	0	0	0	0	0	0	0
Operating Income	-	-339.06K	-54.62K	-63.48K	-54.54K	-59.96K	-63.06K	-58.11K	-54.11K	-46.49K
EBITDA	-	-	-	-	-	-	-63.06K	-58.11K	-54.11K	-46.49K
Net Income	-	-339.06K	-54.62K	-63.48K	-54.54K	-59.96K	-63.06K	-58.11K	-54.11K	-46.49K
Interest Expense	0	0	0	0	0	0	-	-	-	-

Balance Sheet

Currency: USD	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	-	1.38K	3.46K	13.15K	81.83K	10.79K	3.00K	2.31K	3.48K	2.23K
Total Liabilities	-	90.64K	137.28K	50.42K	178.16K	92.01K	69.23K	129.30K	172.01K	226.33K
Total Equity	-	-89.27K	-133.82K	-37.27K	-96.34K	-81.22K	-66.23K	-126.98K	-168.53K	-224.11K
Cash	-	629	2.40K	10.96K	79.24K	9.19K	407	713	880	100

Cash Flow

Currency: USD	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-11.16K	-41.45K	-8.30K	-151.46K	72.80K	-145.12K	-8.32K	2.94K	-47.02K	-44.26K
Financing Cash Flow	-	164.23K	164.23K	164.23K	74.79K	74.79K	-3.94K	0	34.62K	52.56K
Capital Expenditure	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	-	-41.45K	-8.30K	-151.46K	72.80K	-145.12K	-8.32K	2.94K	-47.02K	-44.26K
FCF to OCF	-	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%

Earnings

Report Date	Nov 27, 2026
EPS Estimate	-
EPS Actual	-
Surprise	-
Timing	After-hours

Key Statistics & Ratios

Market Cap345.16K

Enterprise Value344.31K

Trailing P/E0.00

Forward P/E0.00

Price / Sales1.40

Price / Book320.49

EPS0.00

Book Value-0.0199

Revenue (TTM)0

Gross Profit (TTM)0

Profit Margin0.00%

Operating Margin0.00%

Return on Equity0.00%

Return on Assets-292.28%

Shares Outstanding17.26M

Shares Float9.43M

Beta1.54

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Dec 19, 20171:10